Stock Price
4.17
Daily Change
0.04 0.97%
Monthly
16.16%
Yearly
136.93%
Q2 Forecast
4.07

EDAP TMS reported EUR-5.01M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AngioDynamics USD -6.35M 4.55M Sep/2025
Boston Scientific USD 1.34B 669M Mar/2026
EDAP TMS EUR -5.01M 586K Sep/2025
Henry Schein USD 107M 6M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Veracyte USD 28.71M 12.44M Mar/2026